サマリー

This report contains market size and forecasts of Swine Respiratory Diseases Treatment in China, including the following market information:
China Swine Respiratory Diseases Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)
China top five Swine Respiratory Diseases Treatment companies in 2020 (%)
The global Swine Respiratory Diseases Treatment market size is expected to growth from US$ XX million in 2020 to US$ XX million by 2027; it is expected to grow at a CAGR of XX% during 2021-2027.
The China Swine Respiratory Diseases Treatment market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
QYResearch has surveyed the Swine Respiratory Diseases Treatment Companies and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
China Swine Respiratory Diseases Treatment Market, By Causative Agent, 2016-2021, 2022-2027 ($ Millions)
China Swine Respiratory Diseases Treatment Market Segment Percentages, By Causative Agent, 2020 (%)
By Causative Agent
Mycoplasma
Bacteria
Virus
Others
By Treatment Type
Vaccines
Drugs
By Administration
Parenteral
Oral

China Swine Respiratory Diseases Treatment Market, By Application, 2016-2021, 2022-2027 ($ Millions)
China Swine Respiratory Diseases Treatment Market Segment Percentages, By Application, 2020 (%)
Veterinary Hospitals
Veterinary Clinics
Pharmacies
Others

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Swine Respiratory Diseases Treatment revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Swine Respiratory Diseases Treatment revenues share in China market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Zoetis
Virbac
Eli Lilly(Elanco)
Merck Animal Health
Boehringer Ingelheim
Ceva Sante Animale
Norbrook
Thermo Fisher Scientific Inc
Vetoquinol
Bimeda holdings PLC
Huvepharma

ページTOPに戻る

目次

1 Introduction to Research & Analysis Reports
1.1 Swine Respiratory Diseases Treatment Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Swine Respiratory Diseases Treatment Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year

2 China Swine Respiratory Diseases Treatment Overall Market Size
2.1 China Swine Respiratory Diseases Treatment Market Size: 2021 VS 2027
2.2 China Swine Respiratory Diseases Treatment Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints

3 Company Landscape
3.1 Top Swine Respiratory Diseases Treatment Players in China Market
3.2 Top China Swine Respiratory Diseases Treatment Companies Ranked by Revenue
3.3 China Swine Respiratory Diseases Treatment Revenue by Companies
3.4 Top 3 and Top 5 Swine Respiratory Diseases Treatment Companies in China Market, by Revenue in 2020
3.5 Companies Swine Respiratory Diseases Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Swine Respiratory Diseases Treatment Players in China Market
3.6.1 List of Tier 1 Swine Respiratory Diseases Treatment Companies in China
3.6.2 List of Tier 2 and Tier 3 Swine Respiratory Diseases Treatment Companies in China

4 Sights by Causative Agent
4.1 Overview
4.1.1 By Causative Agent - China Swine Respiratory Diseases Treatment Market Size Markets, 2021 & 2027
4.1.2 Mycoplasma
4.1.3 Bacteria
4.1.4 Virus
4.1.5 Others
4.2 By Causative Agent - China Swine Respiratory Diseases Treatment Revenue & Forecasts
4.2.1 By Causative Agent - China Swine Respiratory Diseases Treatment Revenue, 2016-2021
4.2.2 By Causative Agent - China Swine Respiratory Diseases Treatment Revenue, 2022-2027
4.2.3 By Causative Agent - China Swine Respiratory Diseases Treatment Revenue Market Share, 2016-2027

5 Sights by Application
5.1 Overview
5.1.1 By Application - China Swine Respiratory Diseases Treatment Market Size, 2021 & 2027
5.1.2 Veterinary Hospitals
5.1.3 Veterinary Clinics
5.1.4 Pharmacies
5.1.5 Others
5.2 By Application - China Swine Respiratory Diseases Treatment Revenue & Forecasts
5.2.1 By Application - China Swine Respiratory Diseases Treatment Revenue, 2016-2021
5.2.2 By Application - China Swine Respiratory Diseases Treatment Revenue, 2022-2027
5.2.3 By Application - China Swine Respiratory Diseases Treatment Revenue Market Share, 2016-2027

6 Swine Respiratory Diseases Treatment Companies Profiles
6.1 Zoetis
6.1.1 Zoetis Company Details
6.1.2 Zoetis Business Overview
6.1.3 Zoetis Swine Respiratory Diseases Treatment Introduction
6.1.4 Zoetis Swine Respiratory Diseases Treatment Revenue in China Market (2016-2021)
6.1.5 Zoetis Recent Developments
6.2 Virbac
6.2.1 Virbac Company Details
6.2.2 Virbac Business Overview
6.2.3 Virbac Swine Respiratory Diseases Treatment Introduction
6.2.4 Virbac Swine Respiratory Diseases Treatment Revenue in China Market (2016-2021)
6.2.5 Virbac Recent Developments
6.3 Eli Lilly(Elanco)
6.3.1 Eli Lilly(Elanco) Company Details
6.3.2 Eli Lilly(Elanco) Business Overview
6.3.3 Eli Lilly(Elanco) Swine Respiratory Diseases Treatment Introduction
6.3.4 Eli Lilly(Elanco) Swine Respiratory Diseases Treatment Revenue in China Market (2016-2021)
6.3.5 Eli Lilly(Elanco) Recent Developments
6.4 Merck Animal Health
6.4.1 Merck Animal Health Company Details
6.4.2 Merck Animal Health Business Overview
6.4.3 Merck Animal Health Swine Respiratory Diseases Treatment Introduction
6.4.4 Merck Animal Health Swine Respiratory Diseases Treatment Revenue in China Market (2016-2021)
6.4.5 Merck Animal Health Recent Developments
6.5 Boehringer Ingelheim
6.5.1 Boehringer Ingelheim Company Details
6.5.2 Boehringer Ingelheim Business Overview
6.5.3 Boehringer Ingelheim Swine Respiratory Diseases Treatment Introduction
6.5.4 Boehringer Ingelheim Swine Respiratory Diseases Treatment Revenue in China Market (2016-2021)
6.5.5 Boehringer Ingelheim Recent Developments
6.6 Ceva Sante Animale
6.6.1 Ceva Sante Animale Company Details
6.6.2 Ceva Sante Animale Business Overview
6.6.3 Ceva Sante Animale Swine Respiratory Diseases Treatment Introduction
6.6.4 Ceva Sante Animale Swine Respiratory Diseases Treatment Revenue in China Market (2016-2021)
6.6.5 Ceva Sante Animale Recent Developments
6.7 Norbrook
6.7.1 Norbrook Company Details
6.7.2 Norbrook Business Overview
6.7.3 Norbrook Swine Respiratory Diseases Treatment Introduction
6.7.4 Norbrook Swine Respiratory Diseases Treatment Revenue in China Market (2016-2021)
6.7.5 Norbrook Recent Developments
6.8 Thermo Fisher Scientific Inc
6.8.1 Thermo Fisher Scientific Inc Company Details
6.8.2 Thermo Fisher Scientific Inc Business Overview
6.8.3 Thermo Fisher Scientific Inc Swine Respiratory Diseases Treatment Introduction
6.8.4 Thermo Fisher Scientific Inc Swine Respiratory Diseases Treatment Revenue in China Market (2016-2021)
6.8.5 Thermo Fisher Scientific Inc Recent Developments
6.9 Vetoquinol
6.9.1 Vetoquinol Company Details
6.9.2 Vetoquinol Business Overview
6.9.3 Vetoquinol Swine Respiratory Diseases Treatment Introduction
6.9.4 Vetoquinol Swine Respiratory Diseases Treatment Revenue in China Market (2016-2021)
6.9.5 Vetoquinol Recent Developments
6.10 Bimeda holdings PLC
6.10.1 Bimeda holdings PLC Company Details
6.10.2 Bimeda holdings PLC Business Overview
6.10.3 Bimeda holdings PLC Swine Respiratory Diseases Treatment Introduction
6.10.4 Bimeda holdings PLC Swine Respiratory Diseases Treatment Revenue in China Market (2016-2021)
6.10.5 Bimeda holdings PLC Recent Developments
6.11 Huvepharma
6.11.1 Huvepharma Company Details
6.11.2 Huvepharma Business Overview
6.11.3 Huvepharma Swine Respiratory Diseases Treatment Introduction
6.11.4 Huvepharma Swine Respiratory Diseases Treatment Revenue in China Market (2016-2021)
6.11.5 Huvepharma Recent Developments

7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer